MIMEDX GROUP, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.27 USD | +0.40% |
|
-0.32% | -28.51% |
| 03-27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
| 03-27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Neutral |
| Resistance | 7.020 | 9.140 | 8.960 |
| Spread/Res. | -10.68% | -31.40% | -30.02% |
| Spread/Supp. | +1.79% | +10.00% | +9.42% |
| Support | 6.160 | 5.700 | 5.730 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- MDXG Stock
- Charts MiMedx Group, Inc.
